Review of clinical trials on effects of oral antioxidants on basic semen and other parameters in idiopathic oligoasthenoteratozoospermia

Senka Imamovic Kumalic, Bojana Pinter, Senka Imamovic Kumalic, Bojana Pinter

Abstract

Infertility affects 50 to 80 million people worldwide. Male factor is a cause of infertility in almost half of cases, mainly due to oligoasthenoteratozoospermia (OAT). With common diagnostic methods no cause can be found in approximately 30% of cases of male infertility due to OAT and these are considered idiopathic. Reactive oxygen species (ROS) play an important role in male infertility and are proved to be higher in infertile men; antioxidants could oppose their effect. The aim of this paper was to review the literature on clinical trials in the period from year 2000 to year 2013 studying the effects of various types of antioxidant supplements on basic and other sperm parameters and pregnancy rates in subfertile males with idiopathic OAT. The majority of studies were randomized and placebo controlled and confirmed beneficial effect of antioxidants on at least one of the semen parameters; the biggest effect was determined on sperm motility. In many of these trials combinations of more antioxidants were assessed. The optimal dosages of one or more antioxidants were not defined. We concluded that antioxidants play an important role in protecting semen from ROS and can improve basic sperm parameters in case of idiopathic OAT.

References

    1. Sharlip ID, Jarow JP, Belker AM, et al. Best practice policies for male infertility. Fertility and Sterility. 2002;77(5):873–882.
    1. Siddiq FM, Sigman M. A new look at the medical management of infertility. Urologic Clinics of North America. 2002;29(4):949–963.
    1. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Human Reproduction Update. 2009;16(3):231–245.dmp048
    1. Desai N, Sharma R, Makker K, Sabanegh E, Agarwal A. Physiologic and pathologic levels of reactive oxygen species in neat semen of infertile men. Fertility and Sterility. 2009;92(5):1626–1631.
    1. Zini A, San Gabriel M, Baazeem A. Antioxidants and sperm DNA damage: a clinical perspective. Journal of Assisted Reproduction and Genetics. 2009;26(8):427–432.
    1. Agarwal A, Nallella KP, Allamaneni SSR, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reproductive BioMedicine Online. 2004;8(6):616–627.
    1. Griveau JF, Le Lannou D. Reactive oxygen species and human spermatozoa: physiology and pathology. International Journal of Andrology. 1997;20(2):61–69.
    1. Rivlin J, Mendel J, Rubinstein S, Etkovitz N, Breitbart H. Role of hydrogen peroxide in sperm capacitation and acrosome reaction. Biology of Reproduction. 2004;70(2):518–522.
    1. Lopes S, Jurisicova A, Sun J-G, Casper RF. Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Human Reproduction. 1998;13(4):896–900.
    1. Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Human Reproduction. 2010;25(10):2415–2426.
    1. Kao S-H, Chao H-T, Chen H-W, Hwang TIS, Liao T-L, Wei Y-H. Increase of oxidative stress in human sperm with lower motility. Fertility and Sterility. 2008;89(5):1183–1190.
    1. Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biology of Reproduction. 1989;41(1):183–197.
    1. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertility and Sterility. 2003;79(4):829–843.
    1. Zini A, Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian Journal of Andrology. 2011;13(3):374–381.
    1. Alvarez JG, Touchstone JC, Blasco L, Storey BT. Spontaneous lipid peroxidation and production of hydrogen peroxide and superoxide in human spermatozoa. Superoxide dismutase as major enzyme protectant against oxygen toxicity. Journal of Andrology. 1987;8(5):338–348.
    1. Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology. 1996;48(6):835–850.
    1. Smith R, Vantman D, Ponce J, Escobar J, Lissi E. Total antioxidant capacity of human seminal plasma. Human Reproduction. 1996;11(8):1655–1660.
    1. Pahune PP, Choudhari AR, Muley PA. The total antioxidant power of semen and its correlation with the fertility potential of human male subjects. Journal of Clinical and Diagnostic Research. 2013;7(6):991–995.
    1. Wirleitner B, Vanderzwalmen P, Stecher A, et al. Dietary supplementation of antioxidants improves semen quality of IVF patients in terms of motility, sperm count, and nuclear vacuolization. International Journal for Vitamin and Nutrition Research. 2012;82(6):391–398.
    1. Abad C, Amengual MJ, Gosálvez J, et al. Effects of oral antioxidant treatment upon the dynamics of human sperm DNA fragmentation and subpopulations of sperm with highly degraded DNA. Andrologia. 2013;45(3):211–216.
    1. Safarinejad MR. Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study. Andrologia. 2011;43(1):38–47.
    1. Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. Journal of Urology. 2009;182(1):237–248.
    1. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. Journal of Urology. 2012;188(2):526–531.
    1. Safarinejad MR. The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an open-label prospective study. International Urology and Nephrology. 2012;44(3):689–700.
    1. Safarinejad MR. Effect of pentoxifylline on semen parameters, reproductive hormones, and seminal plasma antioxidant capacity in men with idiopathic infertility: a randomized double-blind placebo-controlled study. International Urology and Nephrology. 2011;43(2):315–328.
    1. Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertility and Sterility. 2010;93(7):2232–2235.
    1. Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-Acetyl-Cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. Journal of Urology. 2009;181(2):741–751.
    1. Akmal M, Qadri JQ, Al-Waili NS, Thangal S, Haq A, Saloom KY. Improvement in human semen quality after oral supplementation of vitamin C. Journal of Medicinal Food. 2006;9(3):440–442.
    1. Shi Y, Huang Y, Shang X, Zhu P, Liu G. Effects of xinxibao on sperm quality in oligoasthenozoospermic men. Zhonghua Nan Ke Xue. 2004;10(10):758–760.
    1. Suzuki M, Kurabayashi T, Yamamoto Y, Fujita K, Tanaka K. Effects of antioxidant treatment in oligozoospermic and asthenozoospermic men. Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2003;48(9):707–712.
    1. Gupta NP, Kumar R. Lycopene therapy in idiopathic male infertility—a preliminary report. International Urology and Nephrology. 2002;34(3):369–372.
    1. Busetto GM, Koverech A, Messano M, Antonini G, De Berardinis E, Gentile V. Prospective open-label study on the efficacy and tolerability of a combination of nutritional supplements in primary infertile patients with idiopathic astenoteratozoospermia. Archivio Italiano Di Urologia, Andrologia. 2012;84(3):137–140.
    1. Kumar R, Saxena V, Shamsi MB, Venkatesh S, Dada R. Herbo-mineral supplementation in men with idiopathic oligoasthenoteratospermia: a double blind randomized placebo-controlled trial. Indian Journal of Urology. 2011;27(3):357–362.
    1. Chen XF, Li Z, Ping P, Dai JC, Zhang FB, Shang XJ. Efficacy of natural vitamin E on oligospermia and asthenospermia: a prospective multi-centered randomized controlled study of 106 cases. Zhonghua Nan Ke Xue. 2012;18(5):428–431.
    1. Wang Y-X, Yang S-W, Qu C-B, et al. L-carnitine: safe and effective for asthenozoospermia. Zhonghua Nan Ke Xue. 2010;16(5):420–422.
    1. Piomboni P, Gambera L, Serafini F, Campanella G, Morgante G, De Leo V. Sperm quality improvement after natural anti-oxidant treatment of asthenoteratospermic men with leukocytospermia. Asian Journal of Andrology. 2008;10(2):201–206.
    1. Balercia G, Mosca F, Mantero F, et al. Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertility and Sterility. 2004;81(1):93–98.
    1. Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate. International Journal of General Medicine. 2011;4:99–104.
    1. Keskes-Ammar L, Feki-Chakroun N, Rebai T, et al. Sperm oxidative stress and the effect of an oral vitamin e and selenium supplement on semen quality in infertile men. Systems Biology in Reproductive Medicine. 2003;49(2):83–94.
    1. Cavallini G, Magli MC, Crippa A, Ferraretti AP, Gianaroli L. Reduction in sperm aneuploidy levels in severe oligoasthenoteratospermic patients after medical therapy: a preliminary report. Asian Journal of Andrology. 2012;14(4):591–598.
    1. Roseff SJ. Improvement in sperm quality and function with French maritime pine tree bark extract. Journal of Reproductive Medicine for the Obstetrician and Gynecologist. 2002;47(10):821–824.
    1. Song B, He XJ, Jiang HH, Peng YW, Wu H, Cao YX. Compound Xuanju Capsule combined with vitamin E improves sperm chromatin integrity. Zhonghua Nan Ke Xue. 2012;18(12):1105–1107.
    1. Ménézo YJR, Hazout A, Panteix G, et al. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reproductive BioMedicine Online. 2007;14(4, article 2669):418–421.
    1. Greco E, Romano S, Iacobelli M, et al. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Human Reproduction. 2005;20(9):2590–2594.
    1. Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. Journal of Andrology. 2005;26(3):349–353.
    1. Raigani M, Yaghmaei B, Amirjannti N, et al. The micronutrient supplements, zinc sulphate and folic acid, did not ameliorate sperm functional parameters in oligoasthenoteratozoospermic men. Andrologia. 2013
    1. Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2007;47(3):216–221.
    1. Safarinejad MR, Shafiei N, Safarinejad S. A prospective double-blind randomized placebo-controlled study of the effect of saffron (Crocus sativus Linn.) on semen parameters and seminal plasma antioxidant capacity in infertile men with idiopathic oligoasthenoteratozoospermia. Phytotherapy Research. 2011;25(4):508–516.
    1. Nadjarzadeh A, Sadeghi MR, Amirjannati N, et al. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: a randomized double-blind, placebo controlled trial. Journal of Endocrinological Investigation. 2011;34(8):e224–e228.
    1. Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AMA, Depuydt CE. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukotrienes and Essential Fatty Acids. 2000;63(3):159–165.
    1. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th edition. Geneva, Switzerland: WHO Press; 2010.
    1. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th edition. Geneva, Switzerland: WHO Press; 1999.
    1. Irvine DS, Twigg JP, Gordon EL, Fulton N, Milne PA, Aitken RJ. DNA integrity in human spermatozoa: relationships with semen quality. Journal of Andrology. 2000;21(1):33–44.
    1. Franco JG, Jr., Baruffi RLR, Mauri AL, Petersen CG, Oliveira JBA, Vagnini L. Significance of large nuclear vacuoles in human spermatozoa: implications for ICSI. Reproductive BioMedicine Online. 2008;17(1):42–45.
    1. Yanushpolsky EH, Politch JA, Hill JA, Anderson DJ. Is leukocytospermia clinically relevant? Fertility and Sterility. 1996;66(5):822–825.
    1. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G → T and A → C substitutions. The Journal of Biological Chemistry. 1992;267(1):166–172.
    1. Bergmann M, Behre HM, Nieschlag E. Serum FSH and testicular morphology in male infertility. Clinical Endocrinology. 1994;40(1):133–136.
    1. Meeker JD, Godfrey-Bailey L, Hauser R. Relationships between serum hormone levels and semen quality among men from an infertility clinic. Journal of Andrology. 2007;28(3):397–406.
    1. Agarwal A, Sekhon LH. Oxidative stress and antioxidants for idiopathic oligoasthenoteratospermia: is it justified. Indian Journal of Urology. 2011;27(1):74–85.
    1. Mahfouz R, Sharma R, Sharma D, Sabanegh E, Agarwal A. Diagnostic value of the total antioxidant capacity (TAC) in human seminal plasma. Fertility and Sterility. 2009;91(3):805–811.
    1. Jensen TK, Andersson A-M, Hjollund NHI, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. Journal of Clinical Endocrinology and Metabolism. 1997;82(12):4059–4063.
    1. Pierik FH, Burdorf A, De Jong FH, Weber RFA. Inhibin B: a novel marker of spermatogenesis. Annals of Medicine. 2003;35(1):12–20.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅